Skip to main content
Clinical Trials/NL-OMON31942
NL-OMON31942
Not yet recruiting
Not Applicable

A prospective study for the assessment of recurrence risk in stage II colon cancer patients using ColoPrint. - PARSC

Agendia B.V.0 sites100 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
adenocarcinoma of the colon
Sponsor
Agendia B.V.
Enrollment
100
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
Agendia B.V.

Eligibility Criteria

Inclusion Criteria

  • \- adenocarcinoma of the colon
  • \- stage II (1\-III) planned to be treated with radical surgery

Exclusion Criteria

  • \- prior malignancy with the exception of basal cell carcinoma or cervical dysplasia
  • \- any neo\-adjuvant therapy
  • \- synchronous tumors

Outcomes

Primary Outcomes

Not specified

Similar Trials